One-year results for synchronous anterior accessory saphenous vein ablation hold up
Twelve-month results from the SYNCHRONOUS trial, which is evaluating the role of prophylactic anterior accessory saphenous vein (AASV) ablation for the prevention of recurrent...
Penumbra announces FDA clearance of Lightning Flash 2 for the treatment of PE
Penumbra has announced the US Food and Drug Administration (FDA) clearance and launch of Lightning Flash 2, the next generation computer assisted vacuum thrombectomy (CAVT)...
IVC 2024: Next-generation venous devices take center stage
During the 2024 International Venous Conference (April 18-20) in Miami, Florida, Lowell Kabnick, MD (Lake Worth Beach, Florida), gave s presentation on the newest...
IVC 2024: Choosing the right stent for the right situation
Patrick Muck (Cinncinatti, Ohio) provided a state of the venous stent landscape during the 2024 International Vein Congress (IVC; April 18–20) in Miami.
The TriHealth...
